Clinical Trial Update: Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing docetaxel and cyclophosphamide to anthracycline-based chemotherapy in HER2-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anthracycline-based chemotherapy
• docetaxel and cyclophosphamide

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN